SPONSOR
Tanta University
Total Trials
2
Recruiting
2
Phases
Phase 4
Conditions studied: Peripheral NeuropathyMultiple Myeloma, NeoplasmsCalcitoninNeuropathic PainSpinal Cord Injury
Tanta University is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Peripheral Neuropathy, Multiple Myeloma, Neoplasms, Calcitonin, Neuropathic Pain.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Tanta University
How many clinical trials has Tanta University sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Tanta University, of which 2 are actively recruiting participants. These trials cover conditions including Peripheral Neuropathy, Multiple Myeloma, Neoplasms, Calcitonin. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Tanta University research focus on?
Tanta University clinical trials span Peripheral Neuropathy, Multiple Myeloma, Neoplasms, Calcitonin, Neuropathic Pain, Spinal Cord Injury. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Tanta University clinical trial?
To participate in a Tanta University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Tanta University trials with current recruitment status updated daily.
Clinical Trials by Tanta University
NCT07025005 Phase 4
Recruiting
Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM)
Peripheral Neuropathy
NCT05805683
Recruiting
Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury
Calcitonin
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology